raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:85165

Severe achondroplasia-developmental delay-acanthosis nigricans syndrome

Synonyms: SADDAN

Type
Disease
Group
Disorder
Inheritance
Autosomal dominant, Not applicable
Age of onset
Childhood
Status
active

Severe achondroplasia-developmental delay-acanthosis nigricans syndrome is characterised by the association of severe achondroplasia with developmental delay and acanthosis nigricans. It has been described in four unrelated individuals. Structural central nervous system anomalies, seizures and hearing loss were also reported, together with bowing of the clavicle, femur, tibia and fibula in some cases. The syndrome is caused by a Lys650Met substitution in the kinase domain of fibroblast growth factor receptor 3 (encoded by the <i>FGFR3</i> gene; 4p16.3).

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enSevere achondroplasia-developmental delay-acanthosis nigricans syndromeSADDAN
frSyndrome d'achondroplasie sévère-retard de développement-acanthosis nigricans= en
deSchwere Achondroplasie-Entwicklungsverzögerung-Acanthosis nigricans-SyndromSADDAN-Dysplasie
esSíndrome de acondroplasia grave-retraso del desarrollo-acantosis nigricans= en
itSindrome acondroplasia grave -ritardo dello sviluppo-acanthosis nigricans= en
nlErnstige achondroplasie - ontwikkelingsachterstand - acanthosis nigricans-syndroom= en
ptSíndrome de acondroplasia grave-perturbação do desenvolvimento-acantose nigricans= en
plCiężka achondroplazja - opóźnienie rozwoju - rogowacenie ciemne= en
csSyndrom zahrnující achondroplázii, opoždění vývoje a acanthosis nigricans= en
ukСиндром тяжкої ахондроплазії-затримки розвитку-чорного акантозу= en
zh严重软骨发育不全-发育迟缓-黑棘皮病综合征= en
trAğır akondroplazi-gelişme geriliği-akantozis nigrikans sendromu= en

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM616482Evalidated
ICD-10Q77.4NTBTattributedvalidated
ICD-11LD24.0YNTBTattributedvalidated
MONDO0014658Evalidated
UMLSC2674173Evalidated
GARD9443Evalidated
MedDRA10082381Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (4):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
FGFR3Disease-causing germline mutation(s) inAssessedHGNC:3690ENSG000000680781349344p16.3fibroblast growth factor receptor 310053006[PMID]_18076102[PMID]
5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Cases/families5 casesWorldwideCase(s)Validated10053006[PMID]_18076102[PMID]
Point prevalence<1 / 1 000 000—WorldwideClass onlyValidatedORPHANET_10053006[PMID]_18076102[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

14 annotations · validated 2016-06-01
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:0000956Acanthosis nigricans
HP:0009118Aplasia/Hypoplasia of the mandible
HP:0012444Brain atrophy
HP:0012081Enlarged cerebellum
HP:0002197Generalized-onset seizure
HP:0002079Hypoplasia of the corpus callosum
HP:0010864Intellectual disability, severe
HP:0005871Metaphyseal chondrodysplasia
HP:0011344Severe global developmental delay
Frequent (79-30%)
HP:0000889Abnormality of the clavicle
HP:0002980Femoral bowing
HP:0010502Fibular bowing
HP:0000252Microcephaly
HP:0002982Tibial bowing

Run the differential on the 9 obligate / very frequent terms

Annotation source: 10053006[PMID]_10377013[PMID]

7

Sources for this card